Erratum: The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush (Graefe's Archive for Clinical Experimental Ophthalmology 10.1007/s00417-007-0746-7));The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 9, 2008, Pages 1255-1263

  Jehle, Thomas ^a   Dimitriu, C ^a   Auer, S ^a   Knoth, R ^b   Vidal Sanz, M ^c   Gozes, I ^d   Lagreze W A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF MURCIA   (Spain)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

NAP; Neuropeptide; Neuroprotection; Optic nerve crush; Retinal ischemia

Indexed keywords

ASPARAGINYLALANYLPROPYLVALYLSERYLISOLEUCYLPROPYLGLUTAMINE; FLUOROGOLD; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; MALE; MICROGLIA; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; OPTIC NERVE INJURY; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; RETINA ISCHEMIA; WISTAR RAT;

EID: 48449086310     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0867-7     Document Type: Erratum

References (59)

1. Ashur-Fabian O, Giladi E, Furman S, Steingart RA, Wollman Y, Fridkin M, Brenneman DE, Gozes I (2001) Vasoactive intestinal peptide and related molecules induce nitrite accumulation in the extracellular milieu of rat cerebral cortical cultures. Neurosci Lett 307:167-170
2. Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart RA, Giladi E, Gozes I (2003) The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides 24:1413-1423
3. Bakalash S, Kipnis J, Yoles E, Schwartz M (2002) Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent. Invest Ophthalmol Vis Sci 43:2648-2653
4. Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, Perl O, Bassan H, Blat C, Gibney G, Glazner G, Brenneman DE, Gozes I (1999) Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem 72:1283-1293
5. Belokopytov M, Shulman S, Dubinsky G, Gozes I, Belkin M, Rozner M (2006) Neuroprotective treatment with NAP reduces laser-induced retinal damage in rats. Invest Ophthalmol Vis Sci 47:E-Abstract 4820
6. Beni-Adani L, Gozes I, Cohen Y, Assaf Y, Steingart RA, Brenneman DE, Eizenberg O, Trembolver V, Shohami E (2001) A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J Pharmacol Exp Ther 296:57-63
7. Bodeutsch N, Thanos S (2000) Migration of phagocytotic cells and development of the murine intraretinal microglial network: An in vivo study using fluorescent dyes. Glia 32:91-101
8. Braun JS, Tuomanen EI, Cleveland JL (1999) Neuroprotection by caspase inhibitors. Expert Opin Investig Drugs 8:1599-1610
9. Brenneman DE, Eiden LE (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci USA 83:1159-1162
10. Brenneman DE, Glazner G, Hill JM, Hauser J, Davidson A, Gozes I (1998) VIP neurotrophism in the central nervous system: Multiple effectors and identification of a femtomolar-acting neuroprotective peptide. Ann N Y Acad Sci 865:207-212
11. Brenneman DE, Gozes I (1996) A femtomolar-acting neuroprotective peptide. J Clin Invest 97:2299-2307
12. Cellerino A, Arango-Gonzalez B, Pinzon-Duarte G, Kohler K (2003) Brain-derived neurotrophic factor regulates expression of vasoactive intestinal polypeptide in retinal amacrine cells. J Comp Neurol 467:97-104
13. Cheng B, Mattson MP (1994) NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res 640:56-67
14. Divinski I, Mittelman L, Gozes I (2004) A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication. J Biol Chem 279:28531-28538
15. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495-505
16. Fischer D, Pavlidis M, Thanos S (2000) Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture. Invest Ophthalmol Vis Sci 41:3943-3954
17. Gellrich NC, Schramm A, Rustemeyer J, Schon R, Theodor Eysel U (2002) Quantification of the neurodegenerative impact on the visual system following sudden retrobulbar expanding lesions - an experimental model. J Craniomaxillofac Surg 30:230-236
18. Glazner GW, Boland A, Dresse AE, Brenneman DE, Gozes I, Mattson MP (1999) Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced death. J Neurochem 73:2341-2347
19. Gozes I, Avidor R, Yahav Y, Katznelson D, Croce CM, Huebner K (1987) The gene encoding vasoactive intestinal peptide is located on human chromosome 6p21 ⇁ 6qter. Hum Genet 75:41-44
20. Gozes I, Steingart RA, Spier AD (2004) NAP mechanisms of neuroprotection. J Mol Neurosci 24:67-72
21. Heiduschka P, Thanos S (2000) Aurintricarboxylic acid promotes survival and regeneration of axotomised retinal ganglion cells in vivo. Neuropharmacology 39:889-902
22. Henderson CE, Camu W, Mettling C, Gouin A, Poulsen K, Karihaloo M, Rullamas J, Evans T, McMahon SB, Armanini MP et al (1993) Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 363:266-270
23. Jehle T, Kunze D, Wingert K, Bach M, Largreze WA (2007) Modulation of contrast depth and flash frequencies: Effects on visual evoked potentials recorded in awake, freely moving brown Norway rats. Invest Ophthalmol Vis Sci 48:E-Abstract 3756
24. Jehle T, Lagreze WA, Blauth E, Knorle R, Schnierle P, Lucking CH, Feuerstein TJ (2000) Gabapentin-lactam (8-aza-spiro[5,4]decan-9-on; GBP-L) inhibits oxygen glucose deprivation- induced [3H]glutmate release and is a neuroprotective agent in amodel of acute retinal ischemia. Naunyn Schmiedebergs Arch Pharmacol 362:74-81
25. Kacza J, Mohr C, Pannicke T, Kuhrt H, Dietzel J, Fluss M, Richt JA, Vahlenkamp TW, Stahl T, Reichenbach A, Seeger J (2001) Changes of the organotypic retinal organization in Borna virus-infected Lewis rats. J Neurocytol 30:801-820
26. Kacza J, Seeger J (1997) Transcellular labelling of activated retinal microglia following transection of the optic nerve. Inflamm Res 46:430-433
27. Kaplan DR, Miller FD (2006) When a motor goes bad: A kinesin regulates neuronal survival. Cell 125:224-226
28. Kreutzberg GW (1996) Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318
29. Lafuente MP, Villegas-Perez MP, Mayor S, Aguilera ME, Miralles de Imperial J, Vidal-Sanz M (2002) Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: A dose response in vivo study. Exp Eye Res 74:181-189
30. Lafuente MP, Villegas-Perez MP, Sobrado-Calvo P, Garcia-Aviles A, Miralles de Imperial J, Vidal-Sanz M (2001) Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 42:2074-2084
31. Lagreze WA (2001) [Neuroprotection. Bases and possibilities of a future clinical use]. Ophthalmologe 98:235-236
32. Lagreze WA, Knorle R, Bach M, Feuerstein TJ (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 39:1063-1066
33. Lagreze WA, Pielen A, Steingart R, Schlunck G, Hofmann HD, Gozes I, Kirsch M (2005) The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro. Invest Ophthalmol Vis Sci 46:933-938
34. Leahy KM, Ornberg RL, Wang Y, Zhu Y, Gidday JM, Connor JR, Wax MB (2004) Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b. Exp Eye Res 79:131-140
35. Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149-152
36. Leker RR, Teichner A, Grigoriadis N, Ovadia H, Brenneman DE, Fridkin M, Giladi E, Romano J, Gozes I (2002) NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 33:1085-1092
37. Levi-Montalcini R, Angeletti PU (1968) Nerve growth factor. Physiol Rev 48:534-569
38. Levkovitch-Verbin H, Quigley HA, Martin KR, Zack DJ, Pease ME, Valenta DF (2003) A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest Ophthalmol Vis Sci 44:3388-3393
39. Lin LF, Mismer D, Lile JD, Armes LG, Butler ET 3rd, Vannice JL, Collins F (1989) Purification, cloning, and expression of ciliary neurotrophic factor (CNTF). Science 246:1023-1025
40. Midorikawa R, Takei Y, Hirokawa N (2006) KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. Cell 125:371-383
41. Naskar R, Wissing M, Thanos S (2002) Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest Ophthalmol Vis Sci 43:2962-2968
42. Nickells RW (2004) The molecular biology of retinal ganglion cell death: caveats and controversies. Brain Res Bull 62:439-446
43. Osborne NN, Chidlow G, Layton CJ, Wood JP, Casson RJ, Melena J (2004) Optic nerve and neuroprotection strategies. Eye 18:1075-1084
44. Pinhasov A, Mandel S, Torchinsky A, Giladi E, Pittel Z, Goldsweig AM, Servoss SJ, Brenneman DE, Gozes I (2003) Activity-dependent neuroprotective protein: A novel gene essential for brain formation. Brain Res Dev Brain Res 144:83-90
45. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ (2003) Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348:1333-1341
46. Selles-Navarro I, Villegas-Perez MP, Salvador-Silva M, Ruiz-Gomez JM, Vidal-Sanz M (1996) Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci 37:2002-2014
47. Sobrado-Calvo P, Vidal-Sanz M, Villegas-Perez MP (2007) Rat retinal microglial cells under normal conditions, after optic nerve section, and after optic nerve section and intravitreal injection of trophic factors or macrophage inhibitory factor. J Comp Neurol 501:866-878
48. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, Martone JF, Royall RM, Witt KA, Ezrine S (1991) Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med 325:1412-1417
49. Thanos S (1992) Sick photoreceptors attract activated microglia from the ganglion cell layer: A model to study the inflammatory cascades in rats with inherited retinal dystrophy. Brain Res 588:21-28
50. Thanos S, Kacza J, Seeger J, Mey J (1994) Old dyes for new scopes: The phagocytosis- dependent long-term fluorescence labelling of microglial cells in vivo. Trends Neurosci 17:177-182
51. Thanos S, Mey J, Wild M (1993) Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 13:455-466
52. Visochek L, Steingart RA, Vulih-Shultzman I, Klein R, Priel E, Gozes I, Cohen-Armon M (2005) PolyADP-ribosylation is involved in neurotrophic activity. J Neurosci 25:7420-7428
53. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB (1996) Chronic low- dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci 37:1618-1624
54. Watanabe M, Fukuda Y (2002) Survival and axonal regeneration of retinal ganglion cells in adult cats. Prog Retin Eye Res 21:529-553
55. Yoles E, Wheeler LA, Schwartz M (1999) Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 40:65-73
56. Yuan L, Neufeld AH (2001) Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 64:523-532
57. Zaltzman R, Alexandrovich A, Trembovler V, Shohami E, Gozes I (2005) The influence of the peptide NAP on Mac-1-deficient mice following closed head injury. Peptides 26:1520-1527
58. Zemlyak I, Furman S, Brenneman DE, Gozes I (2000) A novel peptide prevents death in enriched neuronal cultures. Regul Pept 96:39-43
59. Zeng XX, Ng YK, Ling EA (2000) Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 17:463-471